The latest news:

• VBL Therapeutics Announces Positive Outcome in the Third and Final DSMC Review of Phase 3 GLOBE Trial Investigating VB-111 in Recurrent GBM        This is a good sign - no safety problems identified and the trial will be allowed to continue until it completes.
  



• FDA simplifies Institutional Review Board review requirements for physicians seeking individual patient expanded access - Drug Information Update         The FDA issued 3 new guidence documents relating to expanded access of experimental drugs.  This makes it a lot easier for your doctor to get permission to use them. Big step, but not enough.  
  

BrainTumor Co-Payment Assistance Program Status:

• CLOSED to new applicants